Ebit Cambio Fecha
3i Infrastructure GBP 280M 101M 2025-12
AstraZeneca USD 3.16B 3.95B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Hikma Pharmaceutical USD 348M 31M 2025-12